Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Hypodermic syringes & needles industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 Usability trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Hypodermic Syringes & Needles Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic disorders
3.2.1.2 Increase in the number of surgeries
3.2.1.3 Increasing demand for syringes for mass vaccination
3.2.1.4 Surged adoption of syringes & needles for blood collection
3.2.2 Industry pitfalls & challenges
3.2.2.1 Risk of needlestick injuries & infection
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By usability
3.3.3 By application
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Technological advancements
3.6 Regulatory scenario
3.6.1 U.S.
3.6.2 Europe
3.7 Key market trends
3.8 Emerging alternatives
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategy dashboard, 2022
Chapter 5 Hypodermic Syringes & Needles Market, By Type
5.1 Key type trends
5.2 Syringes
5.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
5.3 Needles
5.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
Chapter 6 Hypodermic Syringes & Needles Market, By Usability
6.1 Key usability trends
6.2 Disposable
6.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
6.3 Reusable
6.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
Chapter 7 Hypodermic Syringes & Needles Market, By Application
7.1 Key application trends
7.2 Blood collection
7.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
7.3 Drug delivery
7.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
7.4 Vaccination
7.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
7.5 Insulin administration
7.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
7.6 Others
7.6.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
Chapter 8 Hypodermic Syringes & Needles Market, By End-use
8.1 Key end-use trends
8.2 Hospitals
8.2.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
8.3 Ambulatory Surgical Centers
8.3.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
8.4 Diagnostic centers
8.4.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecasts, 2018 - 2032 (USD Million)
Chapter 9 Hypodermic Syringes & Needles Market, By Region
9.1 Key region trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Vietnam
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Colombia
9.5.5 Chile
9.5.6 Peru
9.5.7 Uruguay
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Turkey
9.6.5 Israel
9.6.6 Egypt
Chapter 10 Company Profiles
10.1 Smiths Medical (ICU Medical)
10.2 B. Braun Medical, Inc.
10.3 Becton Dickinson, & Company
10.4 Cardinal Health, Inc.
10.5 Terumo Corporation
10.6 Nipro Corporation
10.7 Lifelong Meditech Private Limited
10.8 Retractable Technologies
10.9 CONNECTICUT HYPODERMICS INC.
10.10 McKesson Corporation
10.11 Medline Industries, Inc.
10.12 Vita Needle Company
10.13 Exelint International
10.14 Vitrex Medical A/S
10.15 Hi-Tech Syringes Pvt Ltd.
